Search results for "postoperative"

showing 10 items of 1034 documents

Efficacy of Three Different Prophylactic Treatments for Postoperative Nausea and Vomiting after Vitrectomy: A Randomized Clinical Trial

2019

Postoperative nausea and vomiting (PONV) after vitreoretinal surgery may potentially be associated with severe complications, such as suprachoroidal hemorrhage. The purpose of the present multicenter clinical trial (NCT02386059) was to assess the efficacy of three different prophylactic treatments for PONV after vitrectomy under local anesthesia. Patients undergoing primary vitrectomy were randomized to the control arm or to one of the treatment arms (4 mg ondansetron, 4 mg dexamethasone, combination of the two drugs). The primary outcome measure was the proportion of complete response (no nausea, no vomiting, no retching, and no use of antiemetic rescue medication) during 24 h after vitrec…

Nauseamedicine.drug_classvitrectomylcsh:Medicinepostoperative nausea and vomitingdexamethasoneArticlelaw.inventionOndansetron03 medical and health sciences0302 clinical medicineRandomized controlled trial030202 anesthesiologylawmedicineAntiemeticRetchingLocal anesthesiabusiness.industrylcsh:RGeneral MedicineondansetronAnesthesia030221 ophthalmology & optometryVomitingdexamethasone; ondansetron; postoperative nausea and vomiting; vitrectomymedicine.symptombusinessPostoperative nausea and vomitingmedicine.drug
researchProduct

Choosing the nephrostomy size after percutaneous nephrolithotomy.

2011

Purpose: To evaluate the effect of nephrostomy tube size on perioperative outcomes of percutaneous nephrolithtotmy (PCNL). Methods: Forty-five well-matched patients with normal renal function were prospectively divided in two nonrandomized groups after uneventful PCNL (to receive either a 22-Fr, group 1 (n = 24 pts), or a 12-Fr nephrostomy tube, group 2 (n = 21 pts)). In all a balloon nephrostomy catheter with detachable funnel (Rüsch Teleflex, Germany) was used. A Visual Analogue Scale (VAS) for measuring the pain was administered 8 and 24 h after the procedure. Postoperative analgesics use (Ketoralac Tromethamine 30 mg), pre- and postoperative Hb, renal function and urinary leaks were reg…

NephrologyAdultMalePostoperative resultmedicine.medical_specialtyPercutaneousUrologymedicine.medical_treatmentUrologyNephrostomy tubeBlood Loss SurgicalPainPCNLSettore MED/24 - UrologiaKidney CalculiRetrospective StudieInternal medicineNephrostomy PercutaneouPostoperative resultsMedicineHumansPercutaneous nephrolithotomyNephrostomy PercutaneousPain MeasurementRetrospective Studiesbusiness.industryPerioperativeLength of StayMiddle AgedSurgeryTreatment OutcomeNephrostomy catheter sizeNephrostomyFemalebusinessHumanWorld journal of urology
researchProduct

Vascular complications following bladder drained, simultaneous pancreas-kidney transplantation: the University of Miami experience

2000

Vascular complications remain a significant nonimmunologic source of pancreas allograft loss. From February 1993 through January 1998, we performed 98 simultaneous pancreas-kidney transplantations (SPK) using pancreatic exocrine bladder drainage in patients with type 1 insulin-dependent diabetes mellitus and end-stage renal disease. They originally received quadruple immunosuppression, and since May 1997 triple immunosuppression protocol (tacrolimus, mycophenolate mofetil, and steroids). The patients' mean age was 37 years (range 24-53 years), including 50 women and 48 men with a mean follow-up of 42 months. The overall rate of vascular complications was 6% (5 patients). The vascular compli…

NephrologyAdultMalemedicine.medical_specialtyTime FactorsUrinary BladderArteriovenous fistulaHospitals UniversityPseudoaneurysmMesenteric VeinsPostoperative ComplicationsMesenteric Artery Superiormedicine.arteryInternal medicinemedicineHumansDiabetic NephropathiesSuperior mesenteric arteryVascular DiseasesSuperior mesenteric veinRetrospective StudiesVenous ThrombosisTransplantationbusiness.industryAnticoagulantsMiddle Agedmedicine.diseaseThrombosisKidney TransplantationSurgerymedicine.anatomical_structureDiabetes Mellitus Type 1Splenic veinFloridaKidney Failure ChronicDrug Therapy CombinationFemalePancreas TransplantationPancreasbusinessAneurysm FalseImmunosuppressive AgentsSpleenTransplant International
researchProduct

Renal tumour surgery in elderly patients.

2008

OBJECTIVE To analyse morbidity, renal function and oncological outcome in patients aged ≥80 years who had surgery for renal tumours, as in the elderly such surgery is controversial in relation to life-expectancy and other causes of death. PATIENTS AND METHODS Between 1990 and 2006, in our institution 1625 patients had surgery to treat solid renal tumours suspected to be renal cell carcinoma (RCC); 62 (4%) were aged ≥80 years (mean 82.5), and 73% of these elderly patients had radical nephrectomy (RN) and 27% nephron-sparing surgery (NSS). Results The median (range) follow-up was 3.1 (0.2–14.1) years (89% of the patients). There was no perioperative mortality. There were only minor complicati…

NephrologyMalemedicine.medical_specialtyUrologymedicine.medical_treatmentRenal functionurologic and male genital diseasesNephrectomyDisease-Free SurvivalPostoperative ComplicationsRenal cell carcinomaInternal medicineMedicineHumansCarcinoma Renal CellSurvival analysisNeoplasm StagingRetrospective StudiesAged 80 and overbusiness.industryAge FactorsPerioperativemedicine.diseasePrognosisSurvival AnalysisNephrectomyKidney NeoplasmsSurgeryTreatment OutcomeFemalebusinessKidney cancerKidney diseaseFollow-Up StudiesBJU international
researchProduct

Progress and controversies in modern treatment of Wilms' tumors.

1995

During the past 25 years the treatment of Wilms' tumors has been refined owing to a series of thoroughly performed clinical studies. The overall prognosis is currently 80% (long-term cures), but different therapeutic issues are still discussed controversially, especially the question of preoperative treatment. A number of different drugs have proved effective in the treatment of Wilms' tumors. It remains to be determined as to which drug combinations are the most effective for which histologic subtype and which stage of disease. It seems that these questions can be answered only if further studies consequently implicate analyses of early and long-term toxicities. The same is true for analys…

NephrologyOncologymedicine.medical_specialtyChemotherapybusiness.industryUrologymedicine.medical_treatmentPostoperative complicationWilms' tumorDiseasemedicine.diseaseCombined Modality TherapyWilms TumorKidney NeoplasmsSurgeryRadiation therapyInternal medicineHistologic typeMedicineHumansStage (cooking)businessChildNeoplasm StagingWorld journal of urology
researchProduct

Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period.

2005

To assess the incidence of complications of conservative renal surgery for renal cell carcinoma in both elective and imperative indications, and its evolution over a 15 year period.From 1988 to 2003, 127 patients underwent partial nephrectomy or tumorectomy for renal cell carcinoma in our department. INDICATIONs were imperative in 42% (n = 53) and elective in 58% (n=74) of cases. Morbidity was retrospectively assessed according to four parameters: 1- Period of surgery: A, from 1988 to 1999 and B, from 2000 to 2003. 2- INDICATION: elective vs. imperative. 3- experience of surgeon: senior vs. junior. 4- Nature of complications: minor or major. Comparative analysis was conducted using Chi-squa…

NephrologyReoperationmedicine.medical_specialtyUrinary FistulaUrologymedicine.medical_treatmentHemorrhageNephrectomyPostoperative ComplicationsRenal cell carcinomaInternal medicineCarcinomamedicineHumansCarcinoma Renal Cellbusiness.industryIncidence (epidemiology)Acute Kidney Injurymedicine.diseaseNephrectomyKidney NeoplasmsSurgeryTreatment OutcomeComplicationbusinessKidney cancerKidney diseaseFollow-Up StudiesEuropean urology
researchProduct

Open Radical Nephrectomy: 35 Years of Experience at the “Luciano Giuliani” Urological Department of the University of Genoa

2006

Objective: Radical nephrectomy remains the gold standard for surgically resectable kidney neoplasms > 4 cm and, in selected cases, also in presence of metastatic disease. We reviewed the records of the patients having surgery at the University of Genoa in the last 35 yr. Methods: We have retrospectively assessed all the radical nephrectomies performed between 1970 and 2005. Among tumours of the kidney subjected to surgical treatment during this period, we found 1105 cases of histologically proven renal cell carcinoma (RCC), 965 of which had records available for the study. The number of cases per year, symptoms at diagnosis, surgical strategy, staging of the tumour, and survival were rev…

Nephrologycancer incidencemedicine.medical_treatmentkidney carcinomamorbiditysepsisRenal cell carcinomacancer diagnosiscancer mortalitynephrectomypostoperative complicationMyocardial infarctioncancer survivaldisease free survivalcancer diagnosiadrenalectomy; article; cancer diagnosis; cancer incidence; cancer mortality; cancer size; cancer staging; cancer surgery; cancer survival; disease free survival; heart infarction; human; kidney carcinoma; lung embolism; lymphadenectomy; metastasis; morbidity; nephrectomy; partial nephrectomy; postoperative complication; priority journal; sepsis; spleen injury; splenectomy; surgical technique; thrombectomyRadical nephrectomyIncidence (epidemiology)articleadrenalectomyRenal cell carcinomaNephrectomypriority journalthrombectomysepsicancer surgerylung embolismmedicine.medical_specialtypartial nephrectomyUrologyheart infarctionsurgical techniquesplenectomyInternal medicinemedicineCarcinomametastasishumanbusiness.industrycancer stagingmedicine.diseaseSurgeryspleen injurycancer sizelymphadenectomySurgerymetastasibusinessKidney cancerKidney diseaseEuropean Urology Supplements
researchProduct

Short stem total hip arthroplasty: Potential explanations for persistent post-surgical thigh pain.

2017

Abstract: Short stem uncemented femoral implants were developed with the aim of preserving proximal bone stock for future revisions, improving biomechanical reconstruction, aiding insertion through smaller incisions and potentially decreasing or limiting the incidence of thigh pain. Despite all the advantages of short stem designs, it remains unclear whether they are able to limit post-surgical thigh pain. In patients with short stem hip arthroplasty and persistent thigh pain, it is of the utmost importance to understand the potential etiologies of this chronic pain for selecting the appropriate treatment strategy. Therefore, this manuscript explores the hypothetical etiologies of persisten…

Nervous systemBiopsychosocial modelmusculoskeletal diseasesCentral Nervous SystemReoperationmedicine.medical_specialtymedicine.medical_treatmentArthroplasty Replacement HipThighProsthesis DesignModels BiologicalNociceptive Pain03 medical and health sciences0302 clinical medicinemedicineHip Prosthesis/adverse effectsHumansNociceptive Pain/etiologyPain Postoperative/etiology030222 orthopedicsPain Postoperativebusiness.industryChronic painNociceptorsGeneral Medicinemedicine.diseaseArthroplastySurgeryBiomechanical Phenomenamedicine.anatomical_structureNociceptionArthroplasty Replacement Hip/adverse effectsThighCentral Nervous System/physiopathologyOrthopedic surgeryEtiologyPhysical therapyHuman medicineHip ProsthesisbusinessNociceptors/physiology030217 neurology & neurosurgeryMedical hypotheses
researchProduct

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis

2014

Background: Data on survival and safety of sorafenib for hepatocellular carcinoma recurrence after liver transplant are still equivocal. Aim: We performed a meta-analysis of published studies, with the aim of estimating the 1-year rates of survival, analysing the variability in survival rates and, finally, identifying the factors associated with a longer survival. Methods: Data from 8 of the 17 selected studies were pooled, while the other 9 were excluded because survival rates were missing. All included studies were retrospective. Results: Overall, the 1-year survival ranged from 18% to 90%. Tumour progression was the main cause of death. The second cause was bleeding, reported only in pat…

NiacinamidePhenylurea CompoundOncologySorafenibmedicine.medical_specialtyCarcinoma HepatocellularHepatocellular carcinomamedicine.medical_treatmentAntineoplastic AgentsLiver transplantationAntineoplastic AgentRecurrenceInternal medicinemedicineHumansIn patientPostoperative PeriodProspective cohort studyLiver transplantSurvival rateCause of deathHepatologybusiness.industryPhenylurea CompoundsLiver NeoplasmsGastroenterologySorafenibmedicine.diseaseLiver TransplantationSurvival RateReceptors Vascular Endothelial Growth FactorLiver NeoplasmHepatocellular carcinomaMeta-analysisNeoplasm Recurrence LocalbusinessHumanmedicine.drugDigestive and Liver Disease
researchProduct

Olfactory function after microscopic endonasal surgery in patients with nasal polyps.

1997

A controlled prospective study on 31 patients with nasal polyps was performed to evaluate the time course of olfactory function after endonasal surgery. A modified Connecticut Chemosensory Clinical Research Center (CCCRC) olfactory function test was used to measure olfactory threshold, odor identification ability, and odor discrimination ability. The test was performed in all patients 1–3 days before surgery (V1), 7–10 days after surgery (V2), and after 1 (V3), 2 (V4), 3 (V5), and 6 (V6) months. Mean olfactory threshold in the CCCRC butanol test was 4.19 at V1 (= moderate hyposmia). At V2, it decreased to 3.46 (= severe hyposmia), before increasing to 5.16 at V3 and 5.22 at V4 (= mild hypo…

Olfactory systemAdultMalemedicine.medical_specialtyTime Factors03 medical and health sciences0302 clinical medicineNasal PolypsmedicineHumansIn patientNasal polypsProspective Studies030223 otorhinolaryngologyProspective cohort studyPostoperative Carebusiness.industryEndoscopyOlfactory PathwaysMiddle Agedmedicine.diseaseSurgerySmellOtorhinolaryngology030220 oncology & carcinogenesisTime courseFemalebusinessAmerican journal of rhinology
researchProduct